This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Mechanical suppression of osteolytic bone metastases in advanced breast cancer patients: a randomised controlled study protocol evaluating safety, feasibility and preliminary efficacy of exercise as a targeted medicine
Trials Open Access 20 December 2018
-
A randomized controlled trial of an exercise intervention targeting cardiovascular and metabolic risk factors for prostate cancer patients from the RADAR trial
BMC Cancer Open Access 02 December 2009
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Galvão DA et al. (2007) Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer. Prostate Cancer Prostatic Dis 10: 340–346
Keating NL et al. (2006) Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol 24: 4448–4456
Saigal CS et al. (2007) Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer. Cancer 110: 1493–1500
D'Amico AV et al. (2007) Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions. J Clin Oncol 25: 2420–2425
Tsai HK et al. (2007) Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality. J Natl Cancer Inst 99: 1516–1524
Helmrich SP et al. (1991) Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 325: 147–152
Trovati M et al. (1984) Influence of physical training on blood glucose control, glucose tolerance, insulin secretion, and insulin action in non-insulin-dependent diabetic patients. Diabetes Care 7: 416–420
Wannamethee SG et al. (1998) Changes in physical activity, mortality, and incidence of coronary heart disease in older men. Lancet 351: 1603–1608
Myers J et al. (2002) Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346: 793–801
Galvão DA et al. (2006) Resistance training and reduction of treatment side effects in prostate cancer patients. Med Sci Sports Exerc 38: 2045–2052
Acknowledgements
We would like to acknowledge The Cancer Council of Western Australia and the Prostate Cancer Foundation of Australia.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Galvão, D., Newton, R., Taaffe, D. et al. Can exercise ameliorate the increased risk of cardiovascular disease and diabetes associated with ADT?. Nat Rev Urol 5, 306–307 (2008). https://doi.org/10.1038/ncpuro1104
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpuro1104
This article is cited by
-
Body weight, fat mass and metabolic complications during androgen deprivation therapy: should urologists recommend exercise and diet to help patients overcome toxicities?
Prostate Cancer and Prostatic Diseases (2021)
-
Mechanical suppression of osteolytic bone metastases in advanced breast cancer patients: a randomised controlled study protocol evaluating safety, feasibility and preliminary efficacy of exercise as a targeted medicine
Trials (2018)
-
Long-term effects of intermittent androgen suppression therapy on lean and fat mass: a 33-month prospective study
Prostate Cancer and Prostatic Diseases (2013)
-
AST-induced bone loss in men with prostate cancer: exercise as a potential countermeasure
Prostate Cancer and Prostatic Diseases (2012)
-
A randomized controlled trial of an exercise intervention targeting cardiovascular and metabolic risk factors for prostate cancer patients from the RADAR trial
BMC Cancer (2009)